John Ransom
Stock Analyst at Raymond James
(3.66)
# 787
Out of 4,918 analysts
228
Total ratings
64.82%
Success rate
15.11%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $158.09 | +26.51% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $262.23 | +46.82% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $237.77 | +127.11% | 13 | Apr 21, 2025 | |
| RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $54.72 | +18.79% | 11 | Mar 5, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $356.97 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.44 | - | 8 | Nov 22, 2024 | |
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $77.83 | +9.21% | 12 | Nov 1, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.53 | +120.75% | 2 | May 16, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $108.53 | -12.47% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.64 | - | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $98.51 | - | 14 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $247.26 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.58 | +47.28% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $26.34 | +13.90% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $12.97 | -7.48% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $62.47 | +36.07% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $104.96 | +0.04% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $5.92 | +69.06% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.74 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.52 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.27 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $21.12 | +373.48% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $46.21 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $25.65 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $138.48 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.28 | - | 2 | Aug 9, 2017 |
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $158.09
Upside: +26.51%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $262.23
Upside: +46.82%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $237.77
Upside: +127.11%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $54.72
Upside: +18.79%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $356.97
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.44
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $77.83
Upside: +9.21%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.53
Upside: +120.75%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $108.53
Upside: -12.47%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.64
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $98.51
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $247.26
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $13.58
Upside: +47.28%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $26.34
Upside: +13.90%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $12.97
Upside: -7.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $62.47
Upside: +36.07%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $104.96
Upside: +0.04%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $5.92
Upside: +69.06%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.74
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.52
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.27
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $21.12
Upside: +373.48%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $46.21
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $25.65
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $138.48
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.28
Upside: -